Literature DB >> 15082920

Cell cycle genes in a mouse mammary hyperplasia model.

Thenaa K Said1, Daniel Medina.   

Abstract

Human mammary epithelial cells emerge spontaneously from senescence, exhibiting eroding telomeric sequences, and ultimately enter crisis to generate the type of chromosomal abnormalities seen in early stages of breast cancer. In a mouse mammary tumor model, the spontaneous escape of senescence can be observed as an increase in DNA synthesis that is reflected by alterations in the cell cycle profile and increases in the expression levels and activities of cell cycle molecular components. This review provides an overview of gene alterations in the cell cycle components in mouse mammary hyperplasia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15082920     DOI: 10.1023/B:JOMG.0000023590.63974.f8

Source DB:  PubMed          Journal:  J Mammary Gland Biol Neoplasia        ISSN: 1083-3021            Impact factor:   2.673


  109 in total

Review 1.  A specific role for cyclin D1 in mammary gland development.

Authors:  P Sicinski; R A Weinberg
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-10       Impact factor: 2.673

2.  Delayed involution of the mammary epithelium in BALB/c-p53null mice.

Authors:  D J Jerry; C Kuperwasser; S R Downing; J Pinkas; C He; E Dickinson; S Marconi; S P Naber
Journal:  Oncogene       Date:  1998-11-05       Impact factor: 9.867

Review 3.  Cell cycle checkpoints: preventing an identity crisis.

Authors:  S J Elledge
Journal:  Science       Date:  1996-12-06       Impact factor: 47.728

4.  Quantitative assessment of promoter hypermethylation during breast cancer development.

Authors:  Ulrich Lehmann; Florian Länger; Henning Feist; Sabine Glöckner; Britta Hasemeier; Hans Kreipe
Journal:  Am J Pathol       Date:  2002-02       Impact factor: 4.307

5.  Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle.

Authors:  A Koff; A Giordano; D Desai; K Yamashita; J W Harper; S Elledge; T Nishimoto; D O Morgan; B R Franza; J M Roberts
Journal:  Science       Date:  1992-09-18       Impact factor: 47.728

6.  Cell cyclins and cyclin-dependent kinase activities in mouse mammary tumor development.

Authors:  T K Said; D Medina
Journal:  Carcinogenesis       Date:  1995-04       Impact factor: 4.944

7.  Immortalization phenotype dissociated from the preneoplastic phenotype in mouse mammary epithelial outgrowths in vivo.

Authors:  D Medina; F S Kittrell
Journal:  Carcinogenesis       Date:  1993-01       Impact factor: 4.944

Review 8.  Cdk inhibitors: on the threshold of checkpoints and development.

Authors:  S J Elledge; J W Harper
Journal:  Curr Opin Cell Biol       Date:  1994-12       Impact factor: 8.382

9.  Cyclin E, a potential prognostic marker for breast cancer.

Authors:  K Keyomarsi; N O'Leary; G Molnar; E Lees; H J Fingert; A B Pardee
Journal:  Cancer Res       Date:  1994-01-15       Impact factor: 12.701

10.  E-Cadherin-dependent growth suppression is mediated by the cyclin-dependent kinase inhibitor p27(KIP1).

Authors:  B St Croix; C Sheehan; J W Rak; V A Flørenes; J M Slingerland; R S Kerbel
Journal:  J Cell Biol       Date:  1998-07-27       Impact factor: 10.539

View more
  1 in total

1.  Transcriptional regulation of p21/CIP1 cell cycle inhibitor by PDEF controls cell proliferation and mammary tumor progression.

Authors:  Jeremy S Schaefer; Yamini Sabherwal; Heidi Y Shi; Venkataraman Sriraman; JoAnne Richards; Alex Minella; David P Turner; Dennis K Watson; Ming Zhang
Journal:  J Biol Chem       Date:  2010-02-05       Impact factor: 5.157

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.